1. Schering Corporation (32 from 1,829 patents)

2. Merck Sharp + Dohme Corp. (18 from 2,405 patents)

3. Ucb Biopharma Sprl (11 from 138 patents)

4. Ucbbiopharma Srl (7 from 109 patents)

5. Pharmacopeia Drug Discovery, Inc. (6 from 52 patents)

6. Pharmacopeia Inc. (5 from 101 patents)

7. Dendreon Corporation (5 from 53 patents)

8. Other (3 from 832,912 patents)

9. Sanofi (3 from 1,456 patents)

1. 11479546 - Antimalarial hexahydropyrimidine analogues

2. 11472794 - Fused imidazole derivatives as IL-17 modulators

3. 11136310 - Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors

4. 11052076 - Spirocyclic indolines as IL-17 modulators

5. 10980814 - Fused pentacyclic imidazole derivatives as modulators of TNF activity

6. 10953019 - Fused pentacyclic imidazole derivatives as modulators of TNF activity

7. 10906919 - Fused pentacyclic imidazole derivatives

8. 10464932 - Iminothiadiazinane dioxide derivatives as plasmepsin V inhibitors

9. 10287299 - Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity

10. 10202405 - Fused pentacyclic imidazole derivatives

11. 10087179 - Fused tricyclic imidazole derivatives as modulators of TNF activity

12. 10004737 - Fused imidazole and pyrazole derivatives as modulators of TNF activity

13. 9932343 - Fused tricyclic benzimidazoles derivatives as modulators of TNF activity

14. 9890174 - Fused Tricyclic imidazole derivatives as modulators of TNF activity

15. 9815797 - Fused bicyclic heteroaromatic derivatives as modulators of TNF activity